Valuation West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233.62 USD | -5.82% |
|
-6.74% | -14.79% |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 17,866 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | -9.74% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 16,979 | 16,704 | 16,402 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | -11.59% | -1.62% | -1.81% |
| P/E ratio | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 31.1x | 27.8x | 25x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 4.89x | 4.52x | 3.94x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.8x | 2.3x | 2.2x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 5.5x | 5.18x | 4.83x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 5.22x | 4.84x | 4.44x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 19.3x | 17.5x | 15.4x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 24.2x | 21.5x | 19x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 34.6x | 38.5x | - |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 2.89% | 2.6% | - |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | - | 0.8777 | 0.9454 | 1.095 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | - | 0.35% | 0.38% | 0.44% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 7.987 | 8.933 | 9.927 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | - | 11% | 10.6% | 11% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,250 | 3,450 | 3,696 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 877.8 | 956 | 1,067 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 701.1 | 778.7 | 865.1 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 579.1 | 647 | 704.9 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -886.2 | -1,162 | -1,464 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 248.06 | 248.06 | 248.06 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 72,021 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.06x | 5.22x | 19.34x | 0.35% | 1.79TCr | ||
| 24.95x | 4.1x | 15.23x | 2.24% | 20TCr | ||
| 21.78x | 3.9x | 13.75x | 3.14% | 12TCr | ||
| 25.53x | 0.21x | 13.54x | 0.66% | 7.04TCr | ||
| 36.44x | 9.09x | 24.42x | 1.06% | 5.7TCr | ||
| 30.81x | 3.39x | 11.72x | 2.37% | 4.71TCr | ||
| 42.34x | 1.44x | 12.57x | 0.31% | 3.52TCr | ||
| 28.19x | 5.03x | 16.33x | -.--% | 2.65TCr | ||
| 28.28x | 3.97x | 14.54x | 1.07% | 2.23TCr | ||
| 21.91x | 2.78x | 11.24x | 1.46% | 1.9TCr | ||
| Average | 29.13x | 3.91x | 15.27x | 1.27% | 6.08TCr | |
| Weighted average by Cap. | 27.29x | 3.90x | 15.20x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















